Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 85 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1414. Clear
Clear
Q2
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View → Q2
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Pharmacy, Trade (domestic/foreign), Financial Institutions/Investments/Securities, Health Issues
View → Q2
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View → Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q2
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate
Pharmacy
View → Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → Q2
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues
View → Q2
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues
View → Q2
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Pharmacy
View → Q2
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View → Q2
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues
View → Q2
THE WASHINGTON TAX & PUBLIC POLICY GROUP for MODERNATX, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · $30,000.00 income
Taxation/Internal Revenue Code
View → Q1
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Pharmacy, Trade (domestic/foreign), Financial Institutions/Investments/Securities, Health Issues
View → RR
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California
Financial Institutions/Investments/Securities, Health Issues, Medicare/Medicaid, Insurance
View → Q1
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View → Q1
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View → Q1
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q1
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Copyright/Patent/Trademark, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs
View → Q1
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $20,000.00 income
Health Issues
View → Q1
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View → Q1
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate
Pharmacy
View → Q1
HOLLAND & KNIGHT LLP for BLACK WOMEN'S HEALTH IMPERATIVE
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income
Health Issues
View → Q1
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues
View →
Page 1 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem